Personnel Information

写真a

ISHIKAWA Toshiaki


Job title

Associate Professor

Mail Address

ishi.srg2@tmd.ac.jp

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1994, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Graduate School, Division of Medical Sciences, Doctor's Course, 2003, Completed

Degree 【 display / non-display

  • MD, PhD

Campus Career 【 display / non-display

  • 1900.01
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Endowed Departments, Department of Translational Oncology, Assistant Professor
  • 2008.11
    -
    2017.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Specialized Surgeries, Junior Associate Professor
  • 2013.10
    -
    2016.02
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Surgical Oncology, Assistant Professor
  • 2014.12
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Specialized Surgeries, Junior Associate Professor
  • 2017.04
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Specialized Surgeries, Associate Professor
  • 2018.04
    -
    2019.04
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Specialized Surgeries, Associate Professor
  • 2019.05
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Systemic Organ Regulation, Specialized Surgeries, Associate Professor

▼display all

Academic Society Affiliations 【 display / non-display

  • Japan Surgical Society

  • The Japanese Society of Gastroenterological Surgery

  • The Japan Society of Clinical Oncology

  • Japanese Cancer Association

  • The Japan Society of Coloproctology

  • American Association for Cancer Research

  • European Society of Medical Oncology

  • The Japanese Society for Hereditary Tumors

  • Japanese Society of Medical Oncology

  • The Japanese Society of Gastroenterology

  • Japan Surgical Association

  • Japan Gastroenterological Endoscopy Society

▼display all

Academic Activity 【 display / non-display

  • 2020.01
    -
    Now
    Japanese Society for Cancer of the colon and Rectum Committee of Guideline for the Treatment of Colorectal Cancer
  • Japanese Society for Cancer of the Colon and Rectum Committee of Hereditary Colorectal cancer
  • Japan Surgical Association councilor

Research Areas 【 display / non-display

  • Digestive surgery

 

Published Papers & Misc 【 display / non-display

  1. Sasaki Megumi, Ishikawa Toshiaki, Ishiguro Megumi, Okazaki Satoshi, Yamauchi Shinichi, Kikuchi Akifumi, Matsuyama Takatoshi, Kawada Kenro, Tokunaga Masanori, Uetake Hiroyuki, Kinugasa Yusuke. The effectiveness of plasma miR-33a-5p as a predictive biomarker for the efficacy of colorectal cancer chemotherapy ONCOLOGY LETTERS. 2021.06; 21 (6): ( DOI )

  2. Ayumi Takaoka, Toshiaki Ishikawa, Satoshi Okazaki, Shuichi Watanabe, Fuyuki Miya, Tatsuhiko Tsunoda, Akifumi Kikuchi, Shinichi Yamauchi, Takatoshi Matsuyama, Masanori Tokunaga, Hiroyuki Uetake, Yusuke Kinugasa. 41. ELF3 Overexpression as Prognostic Biomarker for Recurrence of Stage II Colorectal Cancer. In vivo. 2021.02; 35 (1): 191-201.

  3. Tomiyuki Miura, Megumi Ishiguro, Toshiaki Ishikawa, Satoshi Okazaki, Hironobu Baba, Akifumi Kikuchi, Shinichi Yamauchi, Takatoshi Matsuyama, Hiroyuki Uetake, Yusuke Kinugasa. Methylation of bone morphogenetic protein 2 is associated with poor prognosis in colorectal cancer Oncology letters. 2020.01; 19 (1): 229-238.

  4. Matsuyama T, Ishikawa T, Takahashi N, Yamada Y, Yasuno M, Kawano T, Uetake H, Goel A.. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer. Molecular Cancer. 2019.02; 18 (1): 19. ( PubMed, DOI )

  5. Raju Kandimalla, Feng Gao, Takatoshi Matsuyama, Toshiaki Ishikawa, Hiroyuki Uetake, Naoki Takahashi, Yasuhide Yamada, Carlos R Becerra, Scott Kopetz, Xin Wang, Ajay Goel. Genome-wide discovery and identification of a novel miRNA signature for recurrence prediction in stage II and III colorectal cancer. Clin. Cancer Res.. 2018.08; 24 (16): 3867-3877. ( PubMed, DOI )

  6. Marie Hanaoka, Toshiaki Ishikawa, Megumi Ishiguro, Michiyo Tokura, Shinichi Yamauchi, Akifumi Kikuchi, Hiroyuki Uetake, Masamichi Yasuno, Tatsuyuki Kawano. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia. J. Gastroenterol.. 2017.09; ( PubMed, DOI )

  7. Iwata N, Ishikawa T, Okazaki S, Mogushi K, Baba H, Ishiguro M, Kobayashi H, Tanaka H, Kawano T, Sugihara K, Uetake H.. Clinical significance of methylation and reduced expression of the quaking gene in colorectal cancer. Anticancer Res. 2017.02; 37 489-498.

  8. Orita F, Ishikawa T, Ishiguro M, Okazaki S, Kikuchi A, Yamauchi S, Matsuyama T, Tokunaga M, Uetake H, Kinugasa Y. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia. Molecular and clinical oncology. 2021.09; 15 (3): 192. ( PubMed, DOI )

  9. Nakajima Hiromichi, Fukuoka Shota, Masuishi Toshiki, Takashima Atsuo, Kumekawa Yosuke, Kajiwara Takeshi, Yamazaki Kentaro, Negoro Yuji, Komoda Masato, Makiyama Akitaka, Denda Tadamichi, Hatachi Yukimasa, Suto Takeshi, Sugimoto Naotoshi, Enomoto Masanobu, Ishikawa Toshiaki, Kashiwada Tomomi, Ando Koji, Yuki Satoshi, Okuyama Hiroyuki, Kusaba Hitoshi, Sakai Daisuke, Okamoto Koichi, Tamura Takao, Yamashita Kimihiro, Gosho Masahiko, Moriwaki Toshikazu. Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment FRONTIERS IN ONCOLOGY. 2021.06; 11 688709. ( PubMed, DOI )

  10. Matsudera Shotaro, Kano Yoshihito, Aoyagi Yasuko, Tohyama Kohki, Takahashi Kenta, Kumaki Yuichi, Mitsumura Takahiro, Kimura Koichiro, Onishi Iichiro, Takemoto Akira, Ban Daisuke, Ono Hiroaki, Kudo Atsushi, Oshima Noriko, Ogino Kei, Watanabe Shun, Tani Yukiko, Yamaguchi Takeshi, Nakajima Masanobu, Morita Shinji, Yamaguchi Satoru, Takagi Masatoshi, Ishikawa Toshiaki, Nakagawa Tsuyoshi, Okamoto Kentaro, Uetake Hiroyuki, Tanabe Minoru, Miyake Satoshi, Tsuchioka Takashi, Kojima Kazuyuki, Ikeda Sadakatsu. A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study) ANNALS OF SURGICAL ONCOLOGY. 2021.03; ( PubMed, DOI )

  11. Ueno Hideki, Ishiguro Megumi, Nakatani Eiji, Ishikawa Toshiaki, Uetake Hiroyuki, Murotani Kenta, Matsui Shigeyuki, Teramukai Satoshi, Sugai Tamotsu, Ajioka Yoichi, Maruo Hirotoshi, Kotaka Masahito, Tsujie Masaki, Munemoto Yoshinori, Yamaguchi Takashi, Kuroda Hisashi, Fukunaga Mutsumi, Tomita Naohiro, Sugihara Kenichi. Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial) BRITISH JOURNAL OF CANCER. 2021.03; 124 (6): 1088-1097. ( PubMed, DOI )

  12. Chida Keigo, Kotani Daisuke, Moriwaki Toshikazu, Fukuoka Shota, Masuishi Toshiki, Takashima Atsuo, Kumekawa Yosuke, Kajiwara Takeshi, Yamazaki Kentaro, Komoda Masato, Makiyama Akitaka, Denda Tadamichi, Hatachi Yukimasa, Suto Takeshi, Sugimoto Naotoshi, Enomoto Masanobu, Ishikawa Toshiaki, Kashiwada Tomomi, Ando Koji, Yuki Satoshi, Okita Yoshihiro, Kusaba Hitoshi, Sakai Daisuke, Okamoto Koichi, Tamura Takao, Yamashita Kimihiro, Gosho Masahiko, Shimada Yasuhiro. Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS) FRONTIERS IN ONCOLOGY. 2021.03; 11 576036. ( PubMed, DOI )

  13. Ueno Hideki, Ishiguro Megumi, Nakatani Eiji, Ishikawa Toshiaki, Uetake Hiroyuki, Matsui Shigeyuki, Teramukai Satoshi, Murotani Kenta, Ajioka Yoichi, Shimazaki Hideyuki, Maeda Atsuyuki, Takuma Kunio, Yoshida Takefumi, Kambara Takeshi, Matsuda Keiji, Takagane Akinori, Tomita Naohiro, Sugihara Kenichi. Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer Prospective Validation in a Randomized Controlled Study (SACURA Trial) AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2020.12; 44 (12): 1685-1698. ( PubMed, DOI )

  14. Takatoshi Matsuyama, Raju Kandimalla, Toshiaki Ishikawa, Naoki Takahashi, Yasuhide Yamada, Masamichi Yasuno, Yusuke Kinugasa, Torben Frøstrup Hansen, Marwan Fakih, Hiroyuki Uetake, Balázs Győrffy, Ajay Goel . A novel mesenchymal-associated transcriptomic signature for risk-stratification and therapeutic response prediction in colorectal cancer International journal of cancer. 2020.07; Online ahead of print

  15. Moriwaki Toshikazu, Fukuoka Shota, Masuishi Toshiki, Takashima Atsuo, Kumekawa Yosuke, Kajiwara Takeshi, Yamazaki Kentaro, Esaki Taito, Makiyama Akitaka, Denda Tadamichi, Hatachi Yukimasa, Suto Takeshi, Sugimoto Naotoshi, Enomoto Masanobu, Ishikawa Toshiaki, Kashiwada Tomomi, Oki Eiji, Komatsu Yoshito, Tsuji Akihito, Tsuchihashi Kenji, Sakai Daisuke, Ueno Hideki, Tamura Takao, Yamashita Kimihiro, Shimada Yasuhiro. Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2020.04; 25 (4): 614-621. ( PubMed, DOI )

  16. Moriwaki Toshikazu, Fukuoka Shota, Masuishi Toshiki, Takashima Atsuo, Kumekawa Yosuke, Kajiwara Takeshi, Yamazaki Kentaro, Esaki Taito, Makiyama Akitaka, Denda Tadamichi, Hatachi Yukimasa, Suto Takeshi, Sugimoto Naotoshi, Enomoto Masanobu, Ishikawa Toshiaki, Kashiwada Tomomi, Oki Eiji, Komatsu Yoshito, Tsuji Akihito, Tsuchihashi Kenji, Sakai Daisuke, Ueno Hideki, Tamura Takao, Yamashita Kimihiro, Shimada Yasuhiro. 転移性大腸癌患者に対しレゴラフェニブまたはトリフルリジン/チピラシル合剤が示す生存利益を評価するための予後スコア REGOTAS研究の探索的解析(Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study) International Journal of Clinical Oncology. 2020.04; 25 (4): 614-621. ( ichushi )

  17. Nakajima Hiromichi, Fukuoka Shota, Moriwaki Toshikazu, Masuishi Toshiki, Takashima Atsuo, Kumekawa Yosuke, Kajiwara Takeshi, Yamazaki Kentaro, Komoda Masato, Makiyama Akitaka, Denda Tadamichi, Hatachi Yukimasa, Suto Takeshi, Sugimoto Naotoshi, Enomoto Masanobu, Ishikawa Toshiaki, Kashiwada Tomomi, Oki Eiji, Gosho Masahiko, Shimada Yasuhiro. Clinical impact of primary tumor location in patients with metastatic colorectal cancer (mCRC) treated with regorafenib or trifluridine/tipiracil as later-line JOURNAL OF CLINICAL ONCOLOGY. 2020.02; 38 (4):

  18. Ueno Hideki, Ishiguro Megumi, Nakatani Eiji, Ishikawa Toshiaki, Uetake Hiroyuki, Matsuda Chu, Nakamoto Yoshihiko, Kotake Masanori, Kurachi Kiyotaka, Egawa Tomohisa, Yasumasa Keigo, Murata Kohei, Ikawa Osamu, Shinji Seiichi, Murotani Kenta, Matsui Shigeyuki, Teramukai Satoshi, Tomita Naohiro, Sugihara Kenichi. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial JOURNAL OF CLINICAL ONCOLOGY. 2019.08; 37 (22): 1886-+. ( PubMed, DOI )

  19. Ishikawa Toshiaki, Murotani Kenta, Ishiguro Megumi, Nakatani Eiji, Uetake Hiroyuki, Matsui Shigeyuki, Sugihara Kenichi. Novel multi-gene classifier for prediction of relapse-free survival after FU-based adjuvant chemotherapy for stage III colon cancer: A biomarker study of the ACTS-C trial, a randomized controlled study CANCER RESEARCH. 2019.07; 79 (13): ( DOI )

  20. Masuishi Toshiki, Moriwaki Toshikazu, Fukuoka Shota, Takashima Atsuo, Kumekawa Yosuke, Kajiwara Takeshi, Yamazaki Kentaro, Esaki Taito, Makiyama Akitaka, Denda Tadamichi, Satake Hironaga, Suto Takeshi, Sugimoto Naotoshi, Katsumata Kenji, Ishikawa Toshiaki, Kashiwada Tomomi, Oki Eiji, Komatsu Yoshito, Yoshimura Kenichi, Shimada Yasuhiro. Predictive factors for early mortality after initiation of regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2019.05; 37 (15):

  21. Ishikawa Toshiaki, Oki Eiji, Shinto Eiji, Shimokawa Mototsugu, Yamaguchi Shigeki, Ishiguro Megumi, Hasegawa Seiji, Takii Yasumasa, Ishida Hideyuki, Kusumoto Tetsuya, Morita Masaru, Tomita Naohiro, Shiozawa Manabu, Tanaka Masafumi, Ozawa Heita, Hashiguchi Yojiro, Ohnuma Shinobu, Tada Sachiyo, Matsushima Tomoko, Hase Kazuo. The 55 STAR study: Prognostic and predictive value of the 55-gene classifier (55GC) in stage III colon cancer JOURNAL OF CLINICAL ONCOLOGY. 2019.05; 37 (15):

  22. Tsuchihashi Kenji, Ito Mamoru, Moriwaki Toshikazu, Fukuoka Shota, Taniguchi Hiroya, Takashima Atsuo, Kumekawa Yosuke, Kajiwara Takeshi, Yamazaki Kentaro, Esaki Taito, Makiyama Akitaka, Denda Tadamichi, Satake Hironaga, Suto Takeshi, Sugimoto Naotoshi, Katsumata Kenji, Ishikawa Toshiaki, Kashiwada Tomomi, Oki Eiji, Komatsu Yoshito, Okuyama Hiroyuki, Sakai Daisuke, Ueno Hideki, Tamura Takao, Yamashita Kimihiro, Kishimoto Junji, Shimada Yasuhiro, Baba Eishi. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer CLINICAL COLORECTAL CANCER. 2018.12; 17 (4): E687-E697. ( PubMed, DOI )

  23. Kusumoto Tetsuya, Ishiguro Megumi, Nakatani Eiji, Yoshida Motoki, Inoue Tsukasa, Nakamoto Yoshihiko, Shiomi Akio, Takagane Akinori, Sunami Eiji, Shinozaki Hiroharu, Takii Yasumasa, Maeda Atsuyuki, Ojima Hitoshi, Hashida Hiroki, Mukaiya Mitsuhiro, Yokoyama Tadashi, Nakamura Masato, Munemoto Yoshinori, Sugihara Kenichi, Kusunoki Yasuyo, Kinoshita Fumie, Kashiwagi Naoko, Kono Hideki, Kono Kenichi, Inaji Tasuku, Tsumura Hayami, Ogasawara Akinori, Ueda Yuri, Ugimoto Syuichiro, Uetake Hiroyuki, Ishikawa Toshiaki, Takagi Yoko, Saito Aiko, Kishiro Sachiko, Okamoto Yasuyo, Nakagawa Yoko, Kagimura Tatsuo, Fukushima Masanori, Watanabe Toshiaki, Takiuchi Hiroya. Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer ESMO OPEN. 2018.08; 3 (6): ( DOI )

  24. Yamauchi S., Takaoka A., Seki R., Matsumiya Y., Orita F., Sasaki M., Miura T., Kikuchi A., Matsuyama T., Ishiguro M., Ishikawa T., Uetake H., Yasuno M., Kinugasa Y., Sugihara K.. Indication of Extended Lateral Lymph Node Dissection for Patients with Lower Rectal Cancer ANNALS OF SURGICAL ONCOLOGY. 2018.02; 25 S164.

  25. Toshikazu Moriwaki, Shota Fukuoka, Hiroya Taniguchi, Atsuo Takashima, Yusuke Kumekawa, Takeshi Kajiwara, Kentaro Yamazaki, Taito Esaki, Chinatsu Makiyama, Tadamichi Denda, Hironaga Satake, Takeshi Suto, Naotoshi Sugimoto, Masanobu Enomoto, Toshiaki Ishikawa, Tomomi Kashiwada, Masahiko Sugiyama, Yoshito Komatsu, Hiroyuki Okuyama, Eishi Baba, Daisuke Sakai, Tomoki Watanabe, Takao Tamura, Kimihiro Yamashita, Masahiko Gosho, Yasuhiro Shimada. Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. Oncologist. 2018.01; 23 (1): 7-15. ( PubMed, DOI )

  26. Ozawa T, Matsuyama T, Toiyama Y, Takahashi N, Ishikawa T, Uetake H, Yamada Y, Kusunoki M, Calin G, Goel A.. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer. Ann Oncol.. 2017.08; 28 (8): 1882-1888.

  27. Aburatani Tomoki, Inokuchi Mikito, Takagi Yoko, Ishikawa Toshiaki, Okuno Keisuke, Gokita Kentaro, Tomii Chiharu, Tanioka Toshiro, Murase Hideaki, Otsuki Sho, Uetake Hiroyuki, Kojima Kazuyuki, Kawano Tatsuyuki. High expression of P21-activated kinase 5 protein is associated with poor survival in gastric cancer ONCOLOGY LETTERS. 2017.07; 14 (1): 404-410. ( PubMed, DOI )

  28. Hanaoka M, Yasuno M, Ishiguro M, Yamauchi S, Kikuchi A, Tokura M, Ishikawa T, Nakatani E, Uetake H.. Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Colorectal Dis. 2017.06; 32 (6): 847-856.

  29. Hanaoka Marie, Yasuno Masamichi, Ishiguro Megumi, Yamauchi Shinichi, Kikuchi Akifumi, Tokura Michiyo, Ishikawa Toshiaki, Nakatani Eiji, Uetake Hiroyuki. Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2017.06; 32 (6): 847-856. ( PubMed, DOI )

  30. Shinozaki Eiji, Ishiguro Megumi, Nakatani Eiji, Yamaguchi Tatsuro, Nakamura Masato, Miyamoto Yuji, Ojima Hitoshi, Honma Yoshitaka, Gotoh Masahiro, Ishikawa Toshiaki, Takahashi Keiichi, Shimada Yasuhiro, Yoshida Kazuhiro, Mizunuma Nobuyuki, Muro Kei, Komatsu Yoshito, Yamaguchi Kensei, Nakano Hiroshi, Koike Junki, Sugihara Kenichi. A phase II study of panitumumab with FOLFOX or FOLFIRI as first-line chemotherapy for KRAS-wild type metastatic colorectal cancer: The PaFF-J study. JOURNAL OF CLINICAL ONCOLOGY. 2017.02; 35 (4):

  31. Hanaoka M., Ishikawa T., Ishiguro M., Tokura M., Yamauchi S., Kikuchi A., Okazaki S., Yasuno M., Uetake H., Kawano T.. ATF6, a UPR Related Gene, Expression in Malignant Conversion and Progression of Ulcerative Colitis (UC)-Associated and Non-UC-Associated Colorectal Cancer ANNALS OF SURGICAL ONCOLOGY. 2017.02; 24 S74.

  32. Tomii C, Inokuchi M, Takagi Y, Ishikawa T, Otsuki S, Uetake H, Kojima K, Kawano T. TPX2 expression is associated with poor survival in gastric cancer World J Surg Oncol. 2017.01; 15 (1): ( PubMed, DOI )

  33. Nasri B, Inokuchi M, Ishikawa T, Uetake H, Takagi Y, Otsuki S, Kojima K, Kawano T. High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival. BMC clinical pathology. 2017; 17 8. ( PubMed, DOI )

  34. Ishikawa T, Uetake H, Murotani K, Kobunai T, Ishiguro M, Matsi S, Sugihara K.. Genome-wide DNA Copy-number Analysis in ACTS-CC Trial of Adjuvant Chemotherapy for Stage III Colonic Cancer. Anticancer Research. 2016; 36 853-860.

  35. Baba H, Ishikawa T, Mogushi K, Ishiguro M, Uetake H, Tanaka H, Sugihara K.. Identification of SATB1 as a specific biomarker for lymph node metastasis in colorectal cancer. Anticancer Research. 2016; 36 4069-4076.

  36. Masuda T, Ishikawa T, Mogushi K, Okazaki S, Ishiguro M, Iida S, Mizushima H, Tanaka H, Uetake H, Sugihara K.. Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer. Int J Oncol. 2016; 48 (3): 975-982.

  37. Takahashi H, Ishikawa T, Ishiguro M, Okazaki S, Mogushi K, Kobayashi H, Iida S, Mizushima H, Tanaka H, Uetaka H, Sugihara K.. Prognostic significance of Traf2-and Nck-interacting kinase (TNIK) in colorectal cancer. BMC Cancer. 2015.02; 15 794.

  38. Kobayashi Hirotoshi, Kikuchi Akifumi, Okazaki Satoshi, Ishiguro Megumi, Ishikawa Toshiaki, Iida Satoru, Uetake Hiroyuki, Sugihara Kenichi. Diagnostic performance of multidetector row computed tomography for assessment of lymph node metastasis in patients with distal rectal cancer. Ann Surg Oncol. 2015.01; 22 (1): 203-208. ( PubMed, DOI )

  39. Kobayashi Hirotoshi, Kikuchi Akifumi, Okazaki Satoshi, Ishiguro Megumi, Ishikawa Toshiaki, Iida Satoru, Uetake Hiroyuki, Sugihara Kenichi. Over-the-scope-clipping system for anastomotic leak after colorectal surgery: report of two cases. World J Gastroenterol. 2014.06; 20 (24): 7984-7987. ( PubMed, DOI )

  40. Yamauchi S, Iida S, Ishiguro M, Ishikawa T, Uetake H, Sugihara K.. Clinical significance of platelet-derived growth factor-C expression in colorectal cancer. J Cancer Therapy. 2014.01; 5 11-20.

▼display all

Conference Activities & Talks 【 display / non-display

  1. Shinichi Yamauchi, Yasuko Aoyagi, Yudai Yamamoto, Ayumi Takaoka, Hironobu Baba, Akifumi Kikuchi, Satoshi Okazaki, Takatoshi Matsuyama, Toshiaki Ishikawa, Yasuaki Nakajima, Kazuyuki Kojima, Hiroyuki Uetake, Yusuke Kinugasa, Kenichi Sugihara. Clinical significance of extended lateral lymph node dissection for patients with lower rectal cancer: A propensity score analysis in a multicenter retrospective study. SSO 2019 Annual Cancer Symposium (72nd Annual Cancer Symposium of the Society of Surgical Oncology) 2019.03.29 San Diego(USA)

  2. Ishikawa T, Ishiguro M, Nakatani E, Ueno H, Uetake H, Murotani K, Matsui S, Tomita N, Shimada Y, Takahashi K, Kotake K, Watanabe M, Mochizuki H, Teramukai S, Sugihara K. Prognostic impact of MSI and 18qLOH in Stage II colon cancer:Aprospective biomarker study in the SACURA trial. ESMO 2018 2018.10.21 Munich (Germany)

  3. Takatoshi Matsuyama, Raju Kandimalla, Xuan Wang, Toshiaki Ishikawa, Naoki Uetake, Yasuhide Yamada, Masamichi Yasuno, Yusuke Kinugasa, Hiroyuki Uetake, Ajay Goel. A mesenchymal-associated transcriptomic signature has a prognostic and predictive potential in stage II and III colorectal cancer patients. American Association for Cancer Research (AACR 2018) 2018.04.16 Chicago (USA)

  4. Shinichi Yamauchi, Takatoshi Matsuyama, Ayumi Takaoka, Yuriko Matsumiya, Ryota Seki, Fukuichiro Orita, Megumi Sasaki, Tomiyuki Miura, Akifumi Kikuchi, Megumi Ishiguro, Toshiaki Ishikawa, Hiroyuki Uetake, Masamichi Yasuno, Yasuaki Nakajima, Kazuyuki Kojima, Yusuke Kinugasa. Laparoscopic and open surgery for ulcerative colitis. International Association of Surgeons, Gastroenterologists and Oncologists (IASGO2018) 2018.04.12 Tokyo

  5. Tomiyuki Miura, Shinichi Yamauchi, Takatoshi Matsuyama, Megumi Ishiguro, Toshiaki Ishikawa, Yasuaki Nakajima, Kazuyuki Kojima, Masamichi Yasuno, Hiroyuki Uetake, Yusuke Kinugasa. A case of Incarcerated Internal Hernia through a Defect of the Falciform Ligament. International Association of Surgeons, Gastroenterologists and Oncologists (IASGO2018) 2018.04.04 Tokyo

  6. Shinichi Yamauchi, Ayumi Takaoka, Yuriko Matsumiya, Ryota Seki, Fukuichiro Orita, Megumi Sasaki, Tomiyuki Miura, Akifumi Kikuchi, Takatoshi Matsuyama, Megumi Ishiguro, Toshiaki Ishikawa, Masamichi Yasuno, Hiroyuki Uetake, Yusuke Kinugasa, Kenichi Sugihara. Indication of Extended Lateral Lymph Node Dissection for Patients with Lower Rectal Cancer. SSO 2018 Annual Cancer Symposium 2018.03.23 Chicago, US

  7. Miura T, Yamauchi S, Takaoka A, Seki R, Matsumiya Y, Orita F, Sasaki M, Tokura M, Kikuchi A, Matsuyama T, Ishiguro M, Ishikawa T, Uetake H, Yasuno M.. Negative pressure wound therapy for closure of ileostomy and colostomy.. The 1st International Conference of Surgical Infection Society Asia-Pacific 2017.11.29 東京

  8. Yamauchi S, Yasuno M, Takaoka A, Matsumiya Y, Seki R, Orita F, Sasaki M, Miura T, Kikuchi A, Matsuyama T, Ishiguro M, Ishikawa T, Uetake H, Sugihara K.. Clinical significance of extended lateral lymph node dissection for lower rectal cancer.. Asian Surgical Association 21st Asian Congress of Surgery 2017.11.12 東京

  9. Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Murotani K, Matsui S, Tomita N, Shimada Y, Takahashi K, Kotake K, Watanabe M, Mochizuki H, Tramukai S, Sugihara K.. Prognostic impact of tumor budding in Stage II colon cancer: A Prospective study(SACURA trial).. American Society of Clinical Oncology (ASCO) 2017 Annual Meeting 2017.06.02 Chicago (USA)

  10. Ishiguro M, Nakatani E, Ueno H, Ishikawa T, Uetake H, Shimada Y, Takahashi K, Kotake K, Watanabe M, Tomita N, Mochizuki H, Teramukai S, Sugihara K.. Recurrence risk factors and outcome stratification stage II colon cancer patients: A subanalysis of the SACURA trial.. American Society of Clinical Oncology (ASCO) 2017 Annual Meeting 2017.06.02 Chicago (USA)

  11. Ishikawa T, Ishiguro M, Nakatani E, Uetake H, Ueno H, Murotani K, Matsui S, Tomita N, Shimada Y, Takahashi K, Kotake K, Watanabe M, Mochizuki H, Teramukai S, Sugihara K.. Prognostic impact of MSI in stage II colon cancers: An additional translational study of the SACURA trial.. American Society of Clinical Oncology (ASCO) 2017 Annual Meeting 2017.06.02 Chicago (USA)

  12. Yamauchi S, Okazaki S, Kikuchi A, Ishiguro M, Ishikawa T, Uetake H, Yasuno M, Sugihara K.. Prognostic factor of lower rectal cancer with lateral pelvic lymph node metastasis treated with lateral lymph node dissection.. Sosiety of Surgical Oncology (SSO) 2017 Annual Meeting 2017.03.16 Seattle(USA)

  13. Hanaoka M, Ishikawa T, Ishiguro M, Tokura M, Yamauchi S, Kikuchi A, Yasuno M, Uetake H, Kawano T. . ATF6, a UPR related gene, expression in malignant conversion and progression of Ulcerative colitis (UC)-associated and non-UC-associated colorectal cancer. . Sosiety of Surgical Oncology (SSO) 2017 Annual Meeting 2017.03.16 Seattle(USA)

  14. Shinozaki E, Ishiguro M, Nakatani E, Yamaguchi T, Nakamura M, Miyamoto Y, Ojima H, Honma Y, Gotoh M, Ishikawa T, Takahashi K, Shimada Y, Yoshida K, Mizunuma N, Muro K, Komatsu Y, Yamaguchi K, Nakano H, Koike J, Sugihara K.. A phase II study of panitumumab with FOLFOX or FOLFIRI as 1st line chemotherapy for KRAS-wild type metastatic colorectal cancer;the PaFF-J study.. American Society of Clinical Oncology 2018 Gastrointestinal Cancers Symposium (ASCO-GI) 2017.01.21 San Francisco (USA)

  15. Ishikawa T, Uetake H, Ishiguro M, Murotani K, Ueno H, Matsui S, Sugihara K, Tomita N.. MSI, 18qLOH, and clinicopathological features in stage II sporadic colon cancers: Biomarker study in a Phase III study of postoperative adjuvant chemotherapy for stage II colon cancer (SACURA trial). ACCR 2015 2015.04.22 Philadelphia (USA)

  16. Ishikawa T, Uetake H, Murotani K, Kobunai T, Ishiguro M, Matsui S, Sugihara K.. Correlation between DNA copy number and clinicopathological features: Biomarker search using genome-wide analysis of DNA copy number alterations in a phase Ⅲ study of postoperative adjuvant chemotherapy for stage Ⅲ colon cancer (ACTS-CC trial).. European Society of Medical Oncology (ESMO) 2014 Annual Meeting 2014.09.29 Madrid (Spain)

  17. Baba H, Ishikawa T, Iwata N, Takahashi H, Kikuchi A, Okazaki S, Ishiguro M, Kobayashi H, Iida S, Uetake H, Sugihara K.. Identification of a novel biomarker related to lymph node metastasis in colorectal cancer through gene expression analysis.. Annual Society Of Surgical Oncology Cancer 2014(67th SSO) 2014.03.13 Arizona (USA)

▼display all